Top Growth Stocks To Buy Now
Looking to enhance your portfolio with high-growth, financially-robust stocks, but not sure where you should even begin? Stocks such as Central China Real Estate and China Medical System Holdings are deemed to be superior in terms of how much they’re expected to earn and return to shareholders, according to analysts. I would suggest taking a look at my list of companies that compare favourably in all criteria, and consider whether they would add value to your current portfolio.
Central China Real Estate Limited (SEHK:832)
Central China Real Estate Limited, an investment holding company, primarily engages in the property development activities in the People’s Republic of China. Started in 1992, and currently run by Xujun Yuan, the company now has 2,721 employees and with the company’s market capitalisation at HKD HK$8.69B, we can put it in the mid-cap group.
832 is expected to deliver a buoyant earnings growth over the next couple of years of 26.55%, bolstered by an equally impressive revenue growth of 68.04%. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 17.28%. 832’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. A potential addition to your portfolio? Other fundamental factors you should also consider can be found here.
China Medical System Holdings Limited (SEHK:867)
China Medical System Holdings Limited, an investment holding company, produces medicines; and markets, promotes, and sells drugs in the People’s Republic of China. Founded in 1995, and now run by Kong Lam, the company currently employs 3,600 people and with the market cap of HKD HK$42.93B, it falls under the large-cap stocks category.
Driven by the positive double-digit sales growth of 30.54% over the next few years, 867 is expected to deliver an excellent earnings growth of 17.66%. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 23.99%. 867’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Should you add 867 to your portfolio? Have a browse through its key fundamentals here.
TK Group (Holdings) Limited (SEHK:2283)
TK Group (Holdings) Limited, an investment holding company, engages in the manufacture, sale, subcontracting, fabrication, and modification of molds and plastic components in the People’s Republic of China, South East Asia, Hong Kong, Europe, the United States, Mexico, and internationally. Started in 1983, and currently headed by CEO Kin Cheung Yung , the company now has 3,427 employees and has a market cap of HKD HK$5.09B, putting it in the mid-cap category.
Driven by the positive double-digit sales growth of 34.85% over the next few years, 2283 is expected to deliver an excellent earnings growth of 21.02%. It appears that 2283’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 38.53%. 2283’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Thinking of investing in 2283? Have a browse through its key fundamentals here.
For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
